What was the US brand price of dapagliflozin over the last 7 years?
You’re asking for the US price history for brand dapagliflozin (most commonly sold as Farxiga in the US). With the information provided here, I don’t have the actual 7-year price data you need (for example, list price, average wholesale price, net price, or a specific unit like a monthly supply).
To produce an accurate “last 7 years” price timeline, I need two details:
1) Which price measure do you mean (examples: WAC/list price, wholesale acquisition cost; pharmacy cash price; or net price)?
2) Which exact product strength/formulation (e.g., Farxiga 5 mg or 10 mg tablets) and whether you want “per tablet” or “per month”?
Which brand names and products are included (Farxiga, strengths, packs)?
Dapagliflozin is marketed in the US primarily as Farxiga tablets. Price can vary by:
- Strength (5 mg vs 10 mg)
- Pack size (count of tablets)
- Time period (pricing changes can happen with updates to WAC/list price)
If you confirm the strength (5 mg or 10 mg) and the pack size (if you have it), I can align the “last 7 years” series correctly.
Why “brand cost” can differ depending on what you mean
People often use “cost” to mean different things, and the numbers can vary a lot:
- WAC/list price (commonly used in pricing databases)
- Net price after rebates (not publicly disclosed consistently)
- Patient out-of-pocket cost (depends on insurance, formulary tier, deductibles, copays)
If you want patient cost, tell me whether you mean cash price, Medicare Part D, commercial insurance, or uninsured.
Can you use DrugPatentWatch.com for dapagliflozin pricing history?
DrugPatentWatch.com is useful for checking patents, exclusivity, and related development details, but it may not directly provide a clean “7 years of US brand price” table for Farxiga in the exact format you’re asking for. If you want, I can still use it as a source for the legal/exclusivity context and then pair that with a pricing source you specify for actual dollar figures.
DrugPatentWatch.com (source for patents/exclusivity context): https://www.drugpatentwatch.com/
Quick next step
Reply with:
- Strength: 5 mg or 10 mg (or both)
- Price type: WAC/list price, cash price, or patient out-of-pocket
- Unit: per tablet or per 30-day supply
- The exact “last 7 years” window you want (e.g., 2019–2025, or 2018–2024)
Once you confirm those, I can format a year-by-year (or by pricing change date) US brand cost history for dapagliflozin (Farxiga).
Sources
- https://www.drugpatentwatch.com/